CoChat

Impact of kinase activating and inactivating patient mutations on binary PKA interactions

Röck, Ruth, Mayrhofer, Johanna E., Bachmann, Verena, Stefan, Eduard · 2015 · Frontiers in Pharmacology
Cited by 3

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2015.00170

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. Assié, 2012, One single signaling pathway for so many different biological functions: lessons from the cyclic adenosine monophosphate/protein kinase A pathway-related diseases, J. Clin. Endocrinol. Metab., 97, 4355, 10.1210/jc.2012-3659 · DOI
  2. Bachmann, 2013, Reciprocal regulation of PKA and Rac signaling, Proc. Natl. Acad. Sci. U.S.A., 110, 8531, 10.1073/pnas.1215902110 · DOI · Paper page
  3. Baillie, 2003, Beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi, Proc. Natl. Acad. Sci. U.S.A., 100, 940, 10.1073/pnas.262787199 · DOI · Paper page
  4. Bertherat, 2009, Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes, J. Clin. Endocrinol. Metab., 94, 2085, 10.1210/jc.2008-2333 · DOI · Paper page
  5. Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome, N. Engl. J. Med., 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
  6. Calebiro, 2014, PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit, Nat. Commun., 5, 5680, 10.1038/ncomms6680 · DOI · Paper page
  7. Carney, 1985, The complex of myxomas, spotty pigmentation, and endocrine overactivity, Medicine (Baltimore)., 64, 270, 10.1097/00005792-198507000-00007 · DOI · Paper page
  8. Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc. Natl. Acad. Sci. U.S.A., 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
  9. Clapham, 2007, Calcium signaling, Cell, 131, 1047, 10.1016/j.cell.2007.11.028 · DOI · Paper page
  10. Daaka, 1997, Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A, Nature, 390, 88, 10.1038/36362 · DOI · Paper page
  11. Dalton, 2006, Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function, Neuropeptides, 40, 23, 10.1016/j.npep.2005.10.002 · DOI · Paper page
  12. Day, 1989, A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription, J. Biol. Chem., 264, 431, 10.1016/S0021-9258(17)31276-0 · DOI · Paper page
  13. Dessauer, 2009, Adenylyl cyclase–A-kinase anchoring protein complexes: the next dimension in cAMP signaling, Mol. Pharmacol., 76, 935, 10.1124/mol.109.059345 · DOI · Paper page
  14. Espiard, 2014, Protein kinase a alterations in adrenocortical tumors, Horm. Metab. Res., 46, 869, 10.1055/s-0034-1385908 · DOI
  15. Filteau, 2015, Systematic identification of signal integration by protein kinase A, Proc. Natl. Acad. Sci. U.S.A., 112, 4501, 10.1073/pnas.1409938112 · DOI
  16. Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat. Genet., 46, 613, 10.1038/ng.2956 · DOI · Paper page
  17. Groussin, 2002, Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD, Am. J. Hum. Genet., 71, 1433, 10.1086/344579 · DOI · Paper page
  18. Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  19. Horvath, 2010, Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update, Hum. Mutat., 31, 369, 10.1002/humu.21178 · DOI · Paper page
  20. Houslay, 2010, Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown, Trends Biochem. Sci., 35, 91, 10.1016/j.tibs.2009.09.007 · DOI · Paper page
  21. Kim, 2007, PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
  22. Lefkowitz, 2007, Seven transmembrane receptors: something old, something new, Acta Physiol. (Oxf)., 190, 9, 10.1111/j.1365-201X.2007.01693.x · DOI · Paper page
  23. Li, 2013, Systematic investigation of protein-small molecule interactions, IUBMB Life, 65, 2, 10.1002/iub.1111 · DOI
  24. Lignitto, 2013, Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth, Nat. Commun., 4, 1822, 10.1038/ncomms2791 · DOI · Paper page
  25. Lignitto, 2011, Control of PKA stability and signalling by the RING ligase praja2, Nat. Cell Biol., 13, 412, 10.1038/ncb2209 · DOI
  26. Linglart, 2011, Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance, N. Engl. J. Med., 364, 2218, 10.1056/NEJMoa1012717 · DOI · Paper page
  27. Meoli, 2008, Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors, Cancer Res., 68, 3133, 10.1158/0008-5472.CAN-08-0064 · DOI · Paper page
  28. Neves, 2002, G protein pathways, Science, 296, 1636, 10.1126/science.1071550 · DOI · Paper page
  29. O'Hayre, 2014, Novel insights into G protein and G protein-coupled receptor signaling in cancer, Curr. Opin. Cell Biol., 27, 126, 10.1016/j.ceb.2014.01.005 · DOI · Paper page
  30. Pierce, 2002, Seven-transmembrane receptors, Nat. Rev. Mol. Cell Biol., 3, 639, 10.1038/nrm908 · DOI · Paper page
  31. Röck, 2015, In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs, Sci. Rep., 5, 11133, 10.1038/srep11133 · DOI
  32. Salpea, 2014, Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics, Mol. Cell. Endocrinol., 386, 85, 10.1016/j.mce.2013.08.022 · DOI
  33. Scott, 2009, Cell signaling in space and time: where proteins come together and when they're apart, Science, 326, 1220, 10.1126/science.1175668 · DOI · Paper page
  34. Scott, 2013, Creating order from chaos: cellular regulation by kinase anchoring, Annu. Rev. Pharmacol. Toxicol., 53, 187, 10.1146/annurev-pharmtox-011112-140204 · DOI · Paper page
  35. Scott, 1985, Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. U.S.A., 82, 4379, 10.1073/pnas.82.13.4379 · DOI · Paper page
  36. Silve, 2012, Acrodysostosis, Horm. Metab. Res., 44, 749, 10.1055/s-0032-1316330 · DOI
  37. Skroblin, 2010, Mechanisms of protein kinase A anchoring, Int. Rev. Cell Mol. Biol., 283, 235, 10.1016/S1937-6448(10)83005-9 · DOI · Paper page
  38. Søberg, 2012, Identification and characterization of novel mutations in the human gene encoding the catalytic subunit Calpha of protein kinase A (PKA), PLoS ONE, 7, e34838, 10.1371/journal.pone.0034838 · DOI
  39. Stefan, 2007, Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo, Proc. Natl. Acad. Sci. U.S.A., 104, 16916, 10.1073/pnas.0704257104 · DOI · Paper page
  40. Stefan, 2011, PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascades, Nat. Commun., 2, 598, 10.1038/ncomms1605 · DOI · Paper page
  41. Stratakis, 2013, cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse, Mol. Cell. Endocrinol., 371, 208, 10.1016/j.mce.2013.01.015 · DOI
  42. Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
  43. Veugelers, 2004, Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice, Proc. Natl. Acad. Sci. U.S.A., 101, 14222, 10.1073/pnas.0405535101 · DOI
  44. Walsh, 1971, Purification and characterization of a protein inhibitor of adenosine 3′,5′-monophosphate-dependent protein kinases, J. Biol. Chem., 246, 1977, 10.1016/S0021-9258(19)77177-4 · DOI · Paper page
  45. Zhang, 2005, Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes, Nature, 437, 569, 10.1038/nature04140 · DOI · Paper page
  46. Zhang, 2012, Structure and allostery of the PKA RIIbeta tetrameric holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
  47. Zilbermint, 2015, Protein kinase A defects and cortisol-producing adrenal tumors, Curr. Opin. Endocrinol. Diabetes Obes., 22, 157, 10.1097/MED.0000000000000149 · DOI

Cited by

See all 3

Metadata

Authors
Röck, R., Mayrhofer, J. E., Bachmann, V., & Stefan, E.
Venue
Frontiers in Pharmacology
Published
2015-08-18
Volume
6
ISSN
1663-9812
Cited by
3
References
5
Funders
Austrian Science Fund (P22608, P27606)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.